Abstracts (HTML) List of Authors

Aktas, B

The prognostic relevance of urokinase-type plasminogen activator (uPA) in the blood of patients with metastatic breast cancer

Aliferis, C

Significant Overall Survival Improvement In Proliferative Subtype Ovarian Cancer Patients Receiving Bevacizumab

Arnold, N

Imbalances and loss of heterozygosity (LOH) in endometrial carcinoma detected by array based Copy number variations (aCNV)
Array based Copy number variations (aCNV) are able to differ classes in endometrial carcinoma
A Disintegrin and Metalloprotease 17 (ADAM17) and its downstream signaling in chemotherapeutic resistance of ovarian cancer
Funktion des Nectin-4 bei der Entstehung von Resistenzmechanismen im Ovarialkarzinom und die Validierung als potenziell prädiktiver und prognostischer Marker

Banys-Paluchowski, M

Clinical relevance of H-RAS, K-RAS and N-RAS in a large cohort of primary breast cancer patients
The prognostic relevance of urokinase-type plasminogen activator (uPA) in the blood of patients with metastatic breast cancer

Bauerschlag, D

Imbalances and loss of heterozygosity (LOH) in endometrial carcinoma detected by array based Copy number variations (aCNV)
Array based Copy number variations (aCNV) are able to differ classes in endometrial carcinoma

Bauerschlag, DO

A Disintegrin and Metalloprotease 17 (ADAM17) and its downstream signaling in chemotherapeutic resistance of ovarian cancer
Funktion des Nectin-4 bei der Entstehung von Resistenzmechanismen im Ovarialkarzinom und die Validierung als potenziell prädiktiver und prognostischer Marker

Baum, S

Analyse und Vergleich von HPV-Genotypen in unterschiedlichen Regionen des weiblichen Anogenitaltrakts und des Hals-Rachenraums

Baumann, K

Significant Overall Survival Improvement In Proliferative Subtype Ovarian Cancer Patients Receiving Bevacizumab

Beckmann, MW

Cancers in Patients with Endometriosis
TILGen: A Program to Investigate Immune Targets in Breast Cancer Patients – First Results on the Influence of Tumor-Infiltrating Lymphocytes

Beyer, I

Identifizierung von Mutationsprofilen hereditärer BRCA1-assoziierter TNBCs

Blum, S

Cancers in Patients with Endometriosis

Bohle, R

Protein expression of SEC62 in triple-negative breast cancer

Bohle, RM

Identifikation von Prognosefaktoren beim triple-negativen Mammakarzinom

Brandl, AL

TILGen: A Program to Investigate Immune Targets in Breast Cancer Patients – First Results on the Influence of Tumor-Infiltrating Lymphocytes

Bräutigam, K

Analyse und Vergleich von HPV-Genotypen in unterschiedlichen Regionen des weiblichen Anogenitaltrakts und des Hals-Rachenraums

Breitbach, GP

Einflussfaktoren auf den Beginn einer neoadjuvanten Chemotherapie bei Mammakarzinom

Burghaus, S

Cancers in Patients with Endometriosis

de Gregorio, N

Significant Overall Survival Improvement In Proliferative Subtype Ovarian Cancer Patients Receiving Bevacizumab

Dittmer, A

Long-term exposure to carcinoma-associated fibroblasts makes breast cancer cells addictive to integrin β1

Dittmer, J

Long-term exposure to carcinoma-associated fibroblasts makes breast cancer cells addictive to integrin β1

Dowdy, SC

Significant Overall Survival Improvement In Proliferative Subtype Ovarian Cancer Patients Receiving Bevacizumab

du Bois, A

Significant Overall Survival Improvement In Proliferative Subtype Ovarian Cancer Patients Receiving Bevacizumab

Dudziak, D

TILGen: A Program to Investigate Immune Targets in Breast Cancer Patients – First Results on the Influence of Tumor-Infiltrating Lymphocytes

Erber, R

TILGen: A Program to Investigate Immune Targets in Breast Cancer Patients – First Results on the Influence of Tumor-Infiltrating Lymphocytes

Esser, K

Lead structure optimization of compounds identified to induce differentiation in solid tumors

Fasching, PA

The prognostic relevance of urokinase-type plasminogen activator (uPA) in the blood of patients with metastatic breast cancer
Cancers in Patients with Endometriosis
TILGen: A Program to Investigate Immune Targets in Breast Cancer Patients – First Results on the Influence of Tumor-Infiltrating Lymphocytes

Fehm, T

Identifizierung von Mutationsprofilen hereditärer BRCA1-assoziierter TNBCs
Clinical relevance of H-RAS, K-RAS and N-RAS in a large cohort of primary breast cancer patients
PGRMC1 interacts with proteins of the cholesterol synthesis pathway resulting in altered cholesterol metabolism in breast cancer cells
Lead structure optimization of compounds identified to induce differentiation in solid tumors
The prognostic relevance of urokinase-type plasminogen activator (uPA) in the blood of patients with metastatic breast cancer
Cancers in Patients with Endometriosis

Feuerborn, J

Funktion des Nectin-4 bei der Entstehung von Resistenzmechanismen im Ovarialkarzinom und die Validierung als potenziell prädiktiver und prognostischer Marker

Fleisch, M

Cancers in Patients with Endometriosis

Fleischer, E

Lead structure optimization of compounds identified to induce differentiation in solid tumors

Flörkemeier, I

Imbalances and loss of heterozygosity (LOH) in endometrial carcinoma detected by array based Copy number variations (aCNV)
Array based Copy number variations (aCNV) are able to differ classes in endometrial carcinoma

Fröhlich, RL

Identifizierung von Mutationsprofilen hereditärer BRCA1-assoziierter TNBCs

Füger, T

Cancers in Patients with Endometriosis

Gabriel, L

Einflussfaktoren auf den Beginn einer neoadjuvanten Chemotherapie bei Mammakarzinom

Gaß, P

TILGen: A Program to Investigate Immune Targets in Breast Cancer Patients – First Results on the Influence of Tumor-Infiltrating Lymphocytes

Germeyer, A

Cancers in Patients with Endometriosis

Häberle, L

Cancers in Patients with Endometriosis
TILGen: A Program to Investigate Immune Targets in Breast Cancer Patients – First Results on the Influence of Tumor-Infiltrating Lymphocytes

Hack, C

TILGen: A Program to Investigate Immune Targets in Breast Cancer Patients – First Results on the Influence of Tumor-Infiltrating Lymphocytes

Hamann, S

Imbalances and loss of heterozygosity (LOH) in endometrial carcinoma detected by array based Copy number variations (aCNV)
Array based Copy number variations (aCNV) are able to differ classes in endometrial carcinoma

Hartkopf, A

The prognostic relevance of urokinase-type plasminogen activator (uPA) in the blood of patients with metastatic breast cancer

Hartmann, A

TILGen: A Program to Investigate Immune Targets in Breast Cancer Patients – First Results on the Influence of Tumor-Infiltrating Lymphocytes

Hartung, CP

Cancers in Patients with Endometriosis

Hayo, C

Einflussfaktoren auf den Beginn einer neoadjuvanten Chemotherapie bei Mammakarzinom

Hedemann, N

Imbalances and loss of heterozygosity (LOH) in endometrial carcinoma detected by array based Copy number variations (aCNV)
Array based Copy number variations (aCNV) are able to differ classes in endometrial carcinoma
A Disintegrin and Metalloprotease 17 (ADAM17) and its downstream signaling in chemotherapeutic resistance of ovarian cancer
Funktion des Nectin-4 bei der Entstehung von Resistenzmechanismen im Ovarialkarzinom und die Validierung als potenziell prädiktiver und prognostischer Marker

Hein, A

Cancers in Patients with Endometriosis
TILGen: A Program to Investigate Immune Targets in Breast Cancer Patients – First Results on the Influence of Tumor-Infiltrating Lymphocytes

Heitz, F

Significant Overall Survival Improvement In Proliferative Subtype Ovarian Cancer Patients Receiving Bevacizumab

Honisch, E

Identifizierung von Mutationsprofilen hereditärer BRCA1-assoziierter TNBCs

Huebner, H

TILGen: A Program to Investigate Immune Targets in Breast Cancer Patients – First Results on the Influence of Tumor-Infiltrating Lymphocytes

Janni, W

The prognostic relevance of urokinase-type plasminogen activator (uPA) in the blood of patients with metastatic breast cancer

Jud, S

TILGen: A Program to Investigate Immune Targets in Breast Cancer Patients – First Results on the Influence of Tumor-Infiltrating Lymphocytes

Juhasz-Böss, I

Einflussfaktoren auf den Beginn einer neoadjuvanten Chemotherapie bei Mammakarzinom
Protein expression of SEC62 in triple-negative breast cancer
Identifikation von Prognosefaktoren beim triple-negativen Mammakarzinom

Juhasz-Böss, S

Einflussfaktoren auf den Beginn einer neoadjuvanten Chemotherapie bei Mammakarzinom

Karow, D

Imbalances and loss of heterozygosity (LOH) in endometrial carcinoma detected by array based Copy number variations (aCNV)
Array based Copy number variations (aCNV) are able to differ classes in endometrial carcinoma

Kasimir-Bauer, S

The prognostic relevance of urokinase-type plasminogen activator (uPA) in the blood of patients with metastatic breast cancer

Kasoha, M

Protein expression of SEC62 in triple-negative breast cancer
Identifikation von Prognosefaktoren beim triple-negativen Mammakarzinom

Kimmig, R

Significant Overall Survival Improvement In Proliferative Subtype Ovarian Cancer Patients Receiving Bevacizumab

Klinger, A

Lead structure optimization of compounds identified to induce differentiation in solid tumors

Köhrer, K

Identifizierung von Mutationsprofilen hereditärer BRCA1-assoziierter TNBCs

Kommoss, F

Significant Overall Survival Improvement In Proliferative Subtype Ovarian Cancer Patients Receiving Bevacizumab

Kommoss, S

Significant Overall Survival Improvement In Proliferative Subtype Ovarian Cancer Patients Receiving Bevacizumab

Köster, F

Analyse und Vergleich von HPV-Genotypen in unterschiedlichen Regionen des weiblichen Anogenitaltrakts und des Hals-Rachenraums

Kranich, H

TILGen: A Program to Investigate Immune Targets in Breast Cancer Patients – First Results on the Influence of Tumor-Infiltrating Lymphocytes

Kremer, AN

TILGen: A Program to Investigate Immune Targets in Breast Cancer Patients – First Results on the Influence of Tumor-Infiltrating Lymphocytes

Kulik, A

Lead structure optimization of compounds identified to induce differentiation in solid tumors

Lange, J

Cancers in Patients with Endometriosis

Langemann, H

TILGen: A Program to Investigate Immune Targets in Breast Cancer Patients – First Results on the Influence of Tumor-Infiltrating Lymphocytes

Linxweiler, M

Protein expression of SEC62 in triple-negative breast cancer

Ludescher, M

PGRMC1 interacts with proteins of the cholesterol synthesis pathway resulting in altered cholesterol metabolism in breast cancer cells

Lux, MP

TILGen: A Program to Investigate Immune Targets in Breast Cancer Patients – First Results on the Influence of Tumor-Infiltrating Lymphocytes

Ma, S

Significant Overall Survival Improvement In Proliferative Subtype Ovarian Cancer Patients Receiving Bevacizumab

Maass, N

Imbalances and loss of heterozygosity (LOH) in endometrial carcinoma detected by array based Copy number variations (aCNV)
Array based Copy number variations (aCNV) are able to differ classes in endometrial carcinoma
A Disintegrin and Metalloprotease 17 (ADAM17) and its downstream signaling in chemotherapeutic resistance of ovarian cancer
Funktion des Nectin-4 bei der Entstehung von Resistenzmechanismen im Ovarialkarzinom und die Validierung als potenziell prädiktiver und prognostischer Marker

Mackensen, A

TILGen: A Program to Investigate Immune Targets in Breast Cancer Patients – First Results on the Influence of Tumor-Infiltrating Lymphocytes

Mahner, S

Significant Overall Survival Improvement In Proliferative Subtype Ovarian Cancer Patients Receiving Bevacizumab

Maurer, J

KDM 4 Inhibition Targets Breast Cancer Stem-like Cells

Meier, S

Analyse und Vergleich von HPV-Genotypen in unterschiedlichen Regionen des weiblichen Anogenitaltrakts und des Hals-Rachenraums

Metzger, E

KDM 4 Inhibition Targets Breast Cancer Stem-like Cells

Milde-Langosch, K

Clinical relevance of H-RAS, K-RAS and N-RAS in a large cohort of primary breast cancer patients

Müller, C

Einflussfaktoren auf den Beginn einer neoadjuvanten Chemotherapie bei Mammakarzinom

Müller, V

Clinical relevance of H-RAS, K-RAS and N-RAS in a large cohort of primary breast cancer patients
The prognostic relevance of urokinase-type plasminogen activator (uPA) in the blood of patients with metastatic breast cancer

Mustea, A

Imbalances and loss of heterozygosity (LOH) in endometrial carcinoma detected by array based Copy number variations (aCNV)
Array based Copy number variations (aCNV) are able to differ classes in endometrial carcinoma

Nabieva, N

TILGen: A Program to Investigate Immune Targets in Breast Cancer Patients – First Results on the Influence of Tumor-Infiltrating Lymphocytes

Neubauer, H

PGRMC1 interacts with proteins of the cholesterol synthesis pathway resulting in altered cholesterol metabolism in breast cancer cells
Lead structure optimization of compounds identified to induce differentiation in solid tumors

Niederacher, D

Identifizierung von Mutationsprofilen hereditärer BRCA1-assoziierter TNBCs
Lead structure optimization of compounds identified to induce differentiation in solid tumors

Nusilati, A

Imbalances and loss of heterozygosity (LOH) in endometrial carcinoma detected by array based Copy number variations (aCNV)
Array based Copy number variations (aCNV) are able to differ classes in endometrial carcinoma

Oliveira-Ferrer, L

Clinical relevance of H-RAS, K-RAS and N-RAS in a large cohort of primary breast cancer patients

Oppelt, P

Cancers in Patients with Endometriosis

Pantel, K

The prognostic relevance of urokinase-type plasminogen activator (uPA) in the blood of patients with metastatic breast cancer

Park-Simon, TW

Significant Overall Survival Improvement In Proliferative Subtype Ovarian Cancer Patients Receiving Bevacizumab

Pfisterer, J

Significant Overall Survival Improvement In Proliferative Subtype Ovarian Cancer Patients Receiving Bevacizumab

Rabizadeh, S

TILGen: A Program to Investigate Immune Targets in Breast Cancer Patients – First Results on the Influence of Tumor-Infiltrating Lymphocytes

Rack, B

The prognostic relevance of urokinase-type plasminogen activator (uPA) in the blood of patients with metastatic breast cancer

Radosa, J

Einflussfaktoren auf den Beginn einer neoadjuvanten Chemotherapie bei Mammakarzinom
Protein expression of SEC62 in triple-negative breast cancer
Identifikation von Prognosefaktoren beim triple-negativen Mammakarzinom

Rauh, C

TILGen: A Program to Investigate Immune Targets in Breast Cancer Patients – First Results on the Influence of Tumor-Infiltrating Lymphocytes

Reicke, S

Cancers in Patients with Endometriosis

Renner, SP

Cancers in Patients with Endometriosis

Riethdorf, S

The prognostic relevance of urokinase-type plasminogen activator (uPA) in the blood of patients with metastatic breast cancer

Röcken, C

Imbalances and loss of heterozygosity (LOH) in endometrial carcinoma detected by array based Copy number variations (aCNV)
Array based Copy number variations (aCNV) are able to differ classes in endometrial carcinoma

Rody, A

Analyse und Vergleich von HPV-Genotypen in unterschiedlichen Regionen des weiblichen Anogenitaltrakts und des Hals-Rachenraums

Rogmans, C

A Disintegrin and Metalloprotease 17 (ADAM17) and its downstream signaling in chemotherapeutic resistance of ovarian cancer
Funktion des Nectin-4 bei der Entstehung von Resistenzmechanismen im Ovarialkarzinom und die Validierung als potenziell prädiktiver und prognostischer Marker

Rübner, M

TILGen: A Program to Investigate Immune Targets in Breast Cancer Patients – First Results on the Influence of Tumor-Infiltrating Lymphocytes

Rudelius, M

Identifizierung von Mutationsprofilen hereditärer BRCA1-assoziierter TNBCs

Scheuring, S

Identifizierung von Mutationsprofilen hereditärer BRCA1-assoziierter TNBCs

Schick, B

Protein expression of SEC62 in triple-negative breast cancer

Schippert, C

Cancers in Patients with Endometriosis

Schmalfeldt, B

Clinical relevance of H-RAS, K-RAS and N-RAS in a large cohort of primary breast cancer patients

Schmidt, G

Einflussfaktoren auf den Beginn einer neoadjuvanten Chemotherapie bei Mammakarzinom
Protein expression of SEC62 in triple-negative breast cancer
Identifikation von Prognosefaktoren beim triple-negativen Mammakarzinom

Schmidt-Arras, D

A Disintegrin and Metalloprotease 17 (ADAM17) and its downstream signaling in chemotherapeutic resistance of ovarian cancer

Schön, G

The prognostic relevance of urokinase-type plasminogen activator (uPA) in the blood of patients with metastatic breast cancer

Schroeder, W

Significant Overall Survival Improvement In Proliferative Subtype Ovarian Cancer Patients Receiving Bevacizumab

Schüle, R

KDM 4 Inhibition Targets Breast Cancer Stem-like Cells

Schulz-Wendtland, R

TILGen: A Program to Investigate Immune Targets in Breast Cancer Patients – First Results on the Influence of Tumor-Infiltrating Lymphocytes

Sebens, S

A Disintegrin and Metalloprotease 17 (ADAM17) and its downstream signaling in chemotherapeutic resistance of ovarian cancer

Sehouli, J

Significant Overall Survival Improvement In Proliferative Subtype Ovarian Cancer Patients Receiving Bevacizumab

Solomayer, EF

Einflussfaktoren auf den Beginn einer neoadjuvanten Chemotherapie bei Mammakarzinom
The prognostic relevance of urokinase-type plasminogen activator (uPA) in the blood of patients with metastatic breast cancer
Protein expression of SEC62 in triple-negative breast cancer
Identifikation von Prognosefaktoren beim triple-negativen Mammakarzinom

Stamm, N

PGRMC1 interacts with proteins of the cholesterol synthesis pathway resulting in altered cholesterol metabolism in breast cancer cells

Stepputtis, SS

KDM 4 Inhibition Targets Breast Cancer Stem-like Cells

Stickeler, E

KDM 4 Inhibition Targets Breast Cancer Stem-like Cells

Stope, MB

Imbalances and loss of heterozygosity (LOH) in endometrial carcinoma detected by array based Copy number variations (aCNV)
Array based Copy number variations (aCNV) are able to differ classes in endometrial carcinoma

Strietz, J

KDM 4 Inhibition Targets Breast Cancer Stem-like Cells

Takacs, Z

Protein expression of SEC62 in triple-negative breast cancer

Taran, FA

Significant Overall Survival Improvement In Proliferative Subtype Ovarian Cancer Patients Receiving Bevacizumab

Tchartchian, G

Cancers in Patients with Endometriosis

Tiemann, K

Imbalances and loss of heterozygosity (LOH) in endometrial carcinoma detected by array based Copy number variations (aCNV)
Array based Copy number variations (aCNV) are able to differ classes in endometrial carcinoma

Tourani, R

Significant Overall Survival Improvement In Proliferative Subtype Ovarian Cancer Patients Receiving Bevacizumab

Treeck, L

Funktion des Nectin-4 bei der Entstehung von Resistenzmechanismen im Ovarialkarzinom und die Validierung als potenziell prädiktiver und prognostischer Marker

Tribian, N

A Disintegrin and Metalloprotease 17 (ADAM17) and its downstream signaling in chemotherapeutic resistance of ovarian cancer

Vesper, AS

Identifizierung von Mutationsprofilen hereditärer BRCA1-assoziierter TNBCs

Volz, B

TILGen: A Program to Investigate Immune Targets in Breast Cancer Patients – First Results on the Influence of Tumor-Infiltrating Lymphocytes

Wang, C

Significant Overall Survival Improvement In Proliferative Subtype Ovarian Cancer Patients Receiving Bevacizumab

Wang, J

Significant Overall Survival Improvement In Proliferative Subtype Ovarian Cancer Patients Receiving Bevacizumab

Weimer, J

Imbalances and loss of heterozygosity (LOH) in endometrial carcinoma detected by array based Copy number variations (aCNV)
Array based Copy number variations (aCNV) are able to differ classes in endometrial carcinoma
A Disintegrin and Metalloprotease 17 (ADAM17) and its downstream signaling in chemotherapeutic resistance of ovarian cancer

Wesch, D

A Disintegrin and Metalloprotease 17 (ADAM17) and its downstream signaling in chemotherapeutic resistance of ovarian cancer

Widschwendter, P

Cancers in Patients with Endometriosis

Winterhoff, BJN

Significant Overall Survival Improvement In Proliferative Subtype Ovarian Cancer Patients Receiving Bevacizumab

Witzel, I

Clinical relevance of H-RAS, K-RAS and N-RAS in a large cohort of primary breast cancer patients
The prognostic relevance of urokinase-type plasminogen activator (uPA) in the blood of patients with metastatic breast cancer

Wunderle, M

TILGen: A Program to Investigate Immune Targets in Breast Cancer Patients – First Results on the Influence of Tumor-Infiltrating Lymphocytes

Yousry Youssef Yanni, C

A Disintegrin and Metalloprotease 17 (ADAM17) and its downstream signaling in chemotherapeutic resistance of ovarian cancer
Funktion des Nectin-4 bei der Entstehung von Resistenzmechanismen im Ovarialkarzinom und die Validierung als potenziell prädiktiver und prognostischer Marker